BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25922704)

  • 1. Correlation between familial cancer history and epidermal growth factor receptor mutations in Taiwanese never smokers with non-small cell lung cancer: a case-control study.
    Cheng PC; Cheng YC
    J Thorac Dis; 2015 Mar; 7(3):281-7. PubMed ID: 25922704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers.
    Chapman AM; Sun KY; Ruestow P; Cowan DM; Madl AK
    Lung Cancer; 2016 Dec; 102():122-134. PubMed ID: 27987580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of smoking status on progression-free and overall survival in non-small cell lung cancer patients receiving erlotinib or gefitinib: a meta-analysis.
    Sohn HS; Kwon JW; Shin S; Kim HS; Kim H
    J Clin Pharm Ther; 2015 Dec; 40(6):661-71. PubMed ID: 26573867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations.
    Kim MH; Kim HR; Cho BC; Bae MK; Kim EY; Lee CY; Lee JS; Kang DR; Kim JH
    Lung Cancer; 2014 May; 84(2):196-202. PubMed ID: 24629638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.
    Soo RA; Kubo A; Ando M; Kawaguchi T; Ahn MJ; Ou SI
    Clin Lung Cancer; 2017 Sep; 18(5):535-542. PubMed ID: 28433570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas.
    Pham D; Kris MG; Riely GJ; Sarkaria IS; McDonough T; Chuai S; Venkatraman ES; Miller VA; Ladanyi M; Pao W; Wilson RK; Singh B; Rusch VW
    J Clin Oncol; 2006 Apr; 24(11):1700-4. PubMed ID: 16505411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between cigarette smoking history, metabolic phenotypes, and
    Zhang X; Guo X; Gao Q; Zhang J; Zheng J; Zhao G; Okuda K; Tartarone A; Jiang M
    J Thorac Dis; 2023 Oct; 15(10):5689-5699. PubMed ID: 37969305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Female sex and bronchioloalveolar pathologic subtype predict EGFR mutations in non-small cell lung cancer.
    Hsieh RK; Lim KH; Kuo HT; Tzen CY; Huang MJ
    Chest; 2005 Jul; 128(1):317-21. PubMed ID: 16002952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer.
    Lee YJ; Cho BC; Jee SH; Moon JW; Kim SK; Chang J; Chung KY; Park IK; Choi SH; Kim JH
    J Clin Oncol; 2010 Jan; 28(3):487-92. PubMed ID: 20008630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent epidermal growth factor receptor mutation patterns between smokers and non-smokers with lung adenocarcinoma.
    Tseng JS; Wang CL; Yang TY; Chen CY; Yang CT; Chen KC; Hsu KH; Tsai CR; Chang GC
    Lung Cancer; 2015 Dec; 90(3):472-6. PubMed ID: 26474957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological subtype and smoking status, but not gender, are associated with
    Hsiao SH; Lin SE; Chou YT; Wang JL; Chung CL; Yu MC; Fang CL; Lee HL; Chiang LL; Liu HE; Wu CW
    Mol Clin Oncol; 2014 Mar; 2(2):252-258. PubMed ID: 24649342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation and polymorphism in the EGFR-TK domain associated with lung cancer.
    Zhang W; Stabile LP; Keohavong P; Romkes M; Grandis JR; Traynor AM; Siegfried JM
    J Thorac Oncol; 2006 Sep; 1(7):635-47. PubMed ID: 17409930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR mutations in non-small-cell lung cancer among smokers and non-smokers: a meta-analysis.
    Ren JH; He WS; Yan GL; Jin M; Yang KY; Wu G
    Environ Mol Mutagen; 2012 Jan; 53(1):78-82. PubMed ID: 22223435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.
    Kim HR; Shim HS; Chung JH; Lee YJ; Hong YK; Rha SY; Kim SH; Ha SJ; Kim SK; Chung KY; Soo R; Kim JH; Cho BC
    Cancer; 2012 Feb; 118(3):729-39. PubMed ID: 21720997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long exposure of environmental tobacco smoke associated with activating EGFR mutations in never-smokers with non-small cell lung cancer.
    Kawaguchi T; Ando M; Kubo A; Takada M; Atagi S; Okishio K; Asami K; Matsumura A; Tsujino K; Ignatius OS; Sasaki H
    Clin Cancer Res; 2011 Jan; 17(1):39-45. PubMed ID: 21059816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: a meta-analysis of prospective randomized trials.
    Hasegawa Y; Ando M; Maemondo M; Yamamoto S; Isa S; Saka H; Kubo A; Kawaguchi T; Takada M; Rosell R; Kurata T; Ou SH
    Oncologist; 2015 Mar; 20(3):307-15. PubMed ID: 25657199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proportion and clinical features of never-smokers with non-small cell lung cancer.
    Cho J; Choi SM; Lee J; Lee CH; Lee SM; Kim DW; Yim JJ; Kim YT; Yoo CG; Kim YW; Han SK; Park YS
    Chin J Cancer; 2017 Feb; 36(1):20. PubMed ID: 28179026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited lung cancer syndromes targeting never smokers.
    Yamamoto H; Yatabe Y; Toyooka S
    Transl Lung Cancer Res; 2018 Aug; 7(4):498-504. PubMed ID: 30225213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Smoking History on the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer Harboring Activating Epidermal Growth Factor Receptor Mutations.
    Igawa S; Sasaki J; Otani S; Ishihara M; Takakura A; Katagiri M; Masuda N
    Oncology; 2015; 89(5):275-80. PubMed ID: 26335629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
    Mounawar M; Mukeria A; Le Calvez F; Hung RJ; Renard H; Cortot A; Bollart C; Zaridze D; Brennan P; Boffetta P; Brambilla E; Hainaut P
    Cancer Res; 2007 Jun; 67(12):5667-72. PubMed ID: 17575133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.